相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Convalescent hyperimmune plasma for chemo-immunotherapy induced immunodeficiency in COVID-19 patients with hematological malignancies
Silvia Ferrari et al.
LEUKEMIA & LYMPHOMA (2021)
Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults
R. Libster et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia
V. A. Simonovich et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Scientific Rigor in the Age of COVID-19
Yu Shyr et al.
JAMA ONCOLOGY (2021)
Convalescent plasma in Covid-19: Possible mechanisms of action
Manuel Rojas et al.
AUTOIMMUNITY REVIEWS (2020)
The convalescent sera option for containing COVID-19
Arturo Casadevall et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
Nicole M. Kuderer et al.
LANCET (2020)
Antibody responses to SARS-CoV-2 in patients with COVID-19
Quan-Xin Long et al.
NATURE MEDICINE (2020)
Real-World Issues and Potential Solutions in Hematopoietic Cell Transplantation during the COVID-19 Pandemic: Perspectives from the Worldwide Network for Blood and Marrow Transplantation and Center for International Blood and Marrow Transplant Research Health Services and International Studies Committee
Ghada Algwaiz et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
Outcomes of COVID-19 in patients with CLL: a multicenter international experience
Anthony R. Mato et al.
BLOOD (2020)
Convalescent plasma therapy for B-cell-depleted patients with protracted COVID-19
Thomas Hueso et al.
BLOOD (2020)
Determinants of COVID-19 disease severity in patients with cancer
Elizabeth V. Robilotti et al.
NATURE MEDICINE (2020)
Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: A COVID-19 and Cancer Consortium (CCC19) cohort study
Donna R Rivera et al.
Cancer Discovery (2020)
Anti-SARS-CoV-2 antibody response in patients with chronic lymphocytic leukemia
Lindsey E. Roeker et al.
LEUKEMIA (2020)
Clinical features associated with COVID-19 outcome in multiple myeloma: first results from the International Myeloma Society data set
Ajai Chari et al.
BLOOD (2020)
A Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19: CCC19 Governance, Protocol, and Quality Assurance
CANCER CELL (2020)
Favorable outcomes of COVID-19 in recipients of hematopoietic cell transplantation
Gunjan L. Shah et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Outcomes of patients with hematologic malignancies and COVID-19: a report from the ASH Research Collaborative Data Hub
William A. Wood et al.
BLOOD ADVANCES (2020)
COVID-19 Infections and Clinical Outcomes in Patients with Multiple Myeloma in New York City: A Cohort Study from Five Academic Centers
Malin Hultcrantz et al.
BLOOD CANCER DISCOVERY (2020)
Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study
Li Tan et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Postoperative acute kidney injury following intraoperative blood product transfusions during cardiac surgery
Bogdan A. Kindzelski et al.
PERFUSION-UK (2018)
The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysis
John Mair-Jenkins et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
分享论文
